(This Oct. 13 story corrects to show that the federal government, not Eli Lilly, made the decision to pause a clinical trial of the company’s antibody drug, paragraph 10) | Video
WASHINGTON The U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters. | Video
A physician who heads the influential U.S. Food and Drug Administration vaccine advisory committee recused herself from the panel's review of COVID-19 vaccines because of her role overseeing a clinical trial for Moderna Inc's candidate, her spokeswoman told Reuters.
Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run.
A top U.S. health regulator who will help decide the fate of a coronavirus vaccine has vowed to resign if the Trump administration approves a vaccine before it is shown to be safe and effective, Reuters has learned.
Aug 20 A top U.S. health regulator who will help decide the fate of a coronavirus vaccine has vowed to resign if the Trump administration approves a vaccine before it is shown to be safe and effective, Reuters has learned.
A man identifying himself as the leader of Nigeria's Boko Haram said on Tuesday the Islamist group was behind the abduction of more than 300 schoolboys, as anxious parents begged the government to secure their release.